"The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing "...
AccuNeb Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
AccuNeb (albuterol sulfate inhalation solution) is used to treat or prevent bronchospasm in patients 2 to 12 years of age with reversible obstructive airway disease. It is also used to prevent exercise-induced bronchospasm. This medication is a bronchodilator. This medication is available in generic form. Common side effects include headache, dizziness, nervousness, sleep problems (insomnia), cough, hoarseness, sore throat, runny or stuffy nose, dry mouth and throat, muscle pain, or diarrhea.
The usual starting dosage of AccuNeb for patients 2 to 12 years of age is 1.25 mg or 0.63 mg administered 3 or 4 times daily, as needed, by nebulization. AccuNeb may interact with diuretics (water pills), digoxin, beta-blockers, antidepressants, MAO inhibitors (MAOIs), or other bronchodilators. Tell your doctor all medications you are taking. AccuNeb should only be used during pregnancy if prescribed. This medication may be harmful to a fetus. It is not known whether this medication passes into breast milk or if it could harm a nursing baby. Consult your doctor before breast-feeding.
Our AccuNeb (albuterol sulfate inhalation solution) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
AccuNeb in Detail - Patient Information: Side Effects
Stop using this medication and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
- bronchospasm (wheezing, chest tightness, trouble breathing), especially after starting a new canister of this medicine;
- chest pain and fast, pounding, or uneven heart beats;
- tremor, nervousness;
- low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling); or
- dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).
Less serious side effects may include:
- headache, dizziness, nervousness;
- sleep problems (insomnia);
- cough, hoarseness, sore throat, runny or stuffy nose;
- dry mouth and throat;
- muscle pain; or
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for AccuNeb (Albuterol Sulfate Inhalation Solution) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
AccuNeb FDA Prescribing Information: Side Effects
Clinical Trial Experience: Adverse events reported in > 1% of patients receiving AccuNeb (albuterol sulfate inhalation solution) and more frequently than in patients receiving placebo in a four-week double-blind study are listed in the following table.
Table 1: Adverse Events with an Incidence of > 1% of Patients
Receiving AccuNeb (albuterol sulfate inhalation solution) and Greater than Placebo (expressed as % of treatment group)
|1.25 mg AccuNeb
|0.63 mg AccuNeb
There was one case of ST segment depression in the 1.25 mg AccuNeb (albuterol sulfate inhalation solution) treatment group.
No clinically relevant laboratory abnormalities related to AccuNeb (albuterol sulfate inhalation solution) administration were seen in this study.
Metabolic acidosis has been reported after the use of albuterol sulfate inhalation solution. Because this reaction is reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate its frequency or establish a causal relationship to drug exposure..
Read the entire FDA prescribing information for AccuNeb (Albuterol Sulfate Inhalation Solution) »
Additional AccuNeb Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.